Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Mature clusters like Telangana and Andhra Pradesh are expected to grow IP volumes at a moderate 5%-6% annually, with Telangana seeing acceleration from new hospital openings like Kondapur and Gachibowli expansions. Expected ARPOB growth of 4-5% annually over next 2-3 years.
From Krishna Institute of Medical Sciences Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Mature clusters like Telangana and Andhra Pradesh are expected to grow IP volumes at a moderate 5%-6% annually, with Telangana seeing acceleration from new hospital openings like Kondapur and Gachibowli expansions.
- New facilities in Bangalore, Thane, and Nashik are in ramp-up stages; Bangalore's hospitals aim to reach EBITDA breakeven by ~30%-40% occupancy within 12 months of commissioning.
- Maharashtra and other micro-markets (Karnataka, Kerala) show strong long-term growth potential with good traction from doctors and unmet demand in Tier 2/3 cities.
- Oncology and other specialty offerings are being expanded to improve case mix and ARPOB, especially in newer and Andhra clusters.
2 more points from Krishna Institute of Medical Sciences Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Krishna Institute of Medical Sciences Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is currently commissioning new hospital beds in multiple locations including Thane, Bangalore, Nashik, and Maharashtra cluster, with phased bed additions planned (e.g., starting with 50-100 beds, gradually increasing to full capacity over 3-4 years).
- Significant greenfield and brownfield expansions are ongoing, particularly in Telangana, Andhra Pradesh, Karnataka, Kerala, and Maharashtra.
- New facilities in Bangalore (800 beds) and Thane (300 beds) are being brought online, with anticipated EBITDA breakeven within 12 months of operation.
- Expansion includes adding specialties such as oncology, pulmonology, cancer care, and mother and child care in Sunshine hospital and other locations.
- Focus is on stabilizing current expansions before initiating new greenfield projects—future expansions will continue around core clusters after FY'27 stabilization.
2 more points from Krishna Institute of Medical Sciences Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Krishna Institute of Medical Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company is currently stabilizing greenfield hospitals commissioned in the current year and plans to start closing on new greenfield hospitals towards the end of the year.
- New greenfield hospital projects typically take 3-4 years to stabilize operations.
- Expansion focus remains on Karnataka, Kerala, Maharashtra, Telangana, and Andhra Pradesh.
- No explicit numeric order book or pending orders mentioned, but the company is actively exploring opportunities within existing clusters.
- Existing announced projects are expected to conclude commissioning by end of FY 2027.
2 more points from Krishna Institute of Medical Sciences Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Krishna Institute of Medical Sciences Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Krishna Institute of Medical Sciences Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Aster DM Quality Care Ltd (Q1 FY26)
Recent quarters saw subdued volume growth due to leadership changes and seasonal effects, but an 8% volume growth was achieved in Q1 FY26, improving from 2% in…
- Dr Agarwals Health Care Ltd (Q1 FY26)
70 crores via preferential allotment to AEHL for CAPEX plans, particularly the flagship facility at Cathedral Road, indicating capacity and service…
- Syngene Intl. (Q1 FY26)
Operating EBITDA grew 21% YoY in Q1 FY '26 with margins rising to ~24% from 22% last year. Key concall takeaways from Syngene International Ltd's Q1 FY26…
- Yatharth Hospital & Trauma Care Services Ltd (Q1 FY26)
International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins. Key concall takeaways from…
Arthneeti Pro · Annual
Krishna Institute of Medical Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Krishna Institute of Medical Sciences Ltd Q1 FY26 results?
Mature clusters like Telangana and Andhra Pradesh are expected to grow IP volumes at a moderate 5%-6% annually, with Telangana seeing acceleration from new hospital openings like Kondapur and Gachibowli expansions. Expected ARPOB growth of 4-5% annually over next 2-3 years.
What is Krishna Institute of Medical Sciences Ltd share price analysis?
Krishna Institute of Medical Sciences Ltd currently shows a neutral. The stock trades at a P/E of 161.5 with a market cap of ₹33,691 Cr. Investors should review the full earnings analysis for detailed insights.
Is Krishna Institute of Medical Sciences Ltd planning capital expenditure?
The company is currently commissioning new hospital beds in multiple locations including Thane, Bangalore, Nashik, and Maharashtra cluster, with phased bed additions planned (e.g., starting with 50-100 beds, gradually increasing to full capacity over 3-4 years).
Keep Krishna Institute of Medical Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.